Novel Coronavirus: A Recent Out Break
The novel Coronavirus was recognised as causative pathogen of coronavirus outbreak in 2020. First case reported in Wuhan. Phylogenetic analysis suggests that an animal sold at seafood market is the host of new virus. Thousands of people already contracted with new coronavirus. The WHO declared the outbreak “public health emergency of international concern”. Coronavirus belongs to large family of virus which are zoonotic in nature. Signs of infection by this virus: respiratory diseases, fever, cough, dyspnoea, headache, hypoxemia, pneumonia, sore throat. Mode of transmission of SARS-CoV  & MERS-CoV  was by cat and dromedary camels. Coronavirus is causing severe acute respiratory syndrome indicated by elevated levels of aminotransferase and lymphopenia; alveolar damage can occur. Etiologic agents of respiratory diseases are human coronavirus: HKUI & HCOU-NL63 and for common cold, it is coronavirus OC43 & 229E. Murine coronavirus exhibit various levels of virulence and tropisms. Antibody & cell mediated responses needed for its prevention. Porcine coronavirus are cause of viral enteritis & foetal diarrhoea. The coronavirus spike protein- mediators cell-cell transmission. 1) Spike cleaves by proteases. 2) then enter cells by plasma membrane route. 3) finally replicate to particular cell based on ability to bind with receptors [2019 n-CoV – can bind to ACE-II receptors]. The demographic states: male: female sex ratio is 2.7-1 and age range 1-76 among the infected. Prevention include: regular hand washing, cover mouth while coughing, thoroughly cook meat and egg. The company Reckitt & Benckiser says that Dettol can kill some CoV strains.
2. Hu B, Ge X, Wang LF, Shi Z. Bat origin of human coronaviruses. Virology journal. 2015 Dec;12(1):221.
3. Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virology journal. 2019 Dec;16(1):69.
4. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020 Mar 27.
5. Shaobo S, Qin M, Shen B. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
6. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine. 2020 Jan 24.
7. Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, Cowling BJ, Lipsitch M, Leung GM. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature Medicine. 2020 Mar 19:1-5.
8. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine. 2020 Apr 16;382(16):1564-7.
9. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020 Mar 16.
10. Drosten C, Meyer B, Müller MA, Corman VM, Al-Masri M, Hossain R, Madani H, Sieberg A, Bosch BJ, Lattwein E, Alhakeem RF. Transmission of MERS-coronavirus in household contacts. New England Journal of Medicine. 2014 Aug 28;371(9):828-35.
11. Madani TA, Azhar EI, Hashem AM. Evidence for camel-to-human transmission of MERS coronavirus. The New England journal of medicine. 2014 Oct 2;371(14):1360.
12. Li W, Wong SK, Li F, Kuhn JH, Huang IC, Choe H, Farzan M. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. Journal of virology. 2006 May 1;80(9):4211-9.
13. Christian MD, Loutfy M, McDonald LC, Martinez KF, Ofner M, Wong T, Wallington T, Gold WL, Mederski B, Green K, Low DE. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerging infectious diseases. 2004 Feb;10(2):287.
14. Cherry JD, Krogstad P. SARS: The First Pandemic of the 21 st Century. Pediatric research. 2004 Jul;56(1):1-5.
15. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb 15;395(10223):497-506.
16. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE. A novel coronavirus associated with severe acute respiratory syndrome. New England journal of medicine. 2003 May 15;348(20):1953-66.
17. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev.. 2005 Dec 1;69(4):635-64.
18. Hogan CA, Sahoo MK, Pinsky BA. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2. Jama. 2020 Apr 6.
19. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KS, Lau EH, Wong JY, Xing X. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020 Jan 29.
20. https://news.cgtn.com/news/2020-03-15/WHO-Over-61-000-people-infected-with-COVID-19-globally-outside-China OS2S1ccHiU/index.html
21. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, Wu C. SARS-CoV-2 infection in children. New England Journal of Medicine. 2020 Mar 18.
22. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. New England Journal of Medicine. 2020 Mar 18.
23. Baden LR, Rubin EJ. Covid-19—the search for effective therapy.2020.
24. Khamitov RA, Loginova S, Shchukina VN, Borisevich SV, Maksimov VA, Shuster AM. Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures. Voprosy virusologii. 2008;53(4):9-13.
25. https://www.worldometers.info.com. COVID-19 Coronavirus pandemic. https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?
26. Balows, A., 2005. Learning from SARS: Preparing for the Next Disease Outbreak, S. Knobler, A. Mahmoud, S. Lemon, A. Mack, L. Sivitz, K. Oberholtzer (Eds.), Institute of Medicine of the National Academies, Washington DC (2004), 359 pp, including 6 appendixes; paperback; $42.00, ISBN: 0-309-09154-3.
27. Vaduganathan M, Vardeny O, Michel T, McMurray JJ, Pfeffer MA, Solomon SD. Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. New England Journal of Medicine. 2020 Mar 30.
28. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. New England Journal of Medicine. 2020 Mar 30.
29. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020 Mar 16.